Skip to main content

Cookies on BBB.org

We use cookies to give users the best content and online experience. By clicking “Accept All Cookies”, you agree to allow us to use all cookies. Visit our Privacy Policy to learn more.

Manage Cookies

Select a Language

About

About This Business

Kale´o provides drug-delivery device technology and auto-injector innovation, including the Aerio platform for medical countermeasures and emergency medicine. The company assists clients with custom-designed drug-delivery devices paired with pharmaceutical breakthroughs.

BBB Accredited Since: 7/2/2007

Years in Business: 32

Products and Services

Anaphylaxis Rescue Medications, Auto-Injector Platform, Drug-Delivery Devices, Drug-Device Combinations, Emergency Medicine, Epinephrine Auto-Injectors, Medical Countermeasures

Business Details

BBB File Opened:
8/7/2007
Business Started:
1/1/1994
Business Incorporated:
12/3/2013
Type of Entity:
Limited Liability Company (LLC)
Alternate Names:
Intelliject
Business Management:
Ms. Carrie Siragusa, Vice President, Marketing and Public Relations

Additional Contact Information

Customer Contacts
Ms. Carrie Siragusa, Vice President, Marketing and Public Relations
Fax numbers
Primary Fax: (804) 545-6219
Additional Email Addresses
Primary: Email this Business

Additional Information

BBB Business Profiles are provided solely to assist you in exercising your own best judgment. BBB does not verify the accuracy of information provided by third parties, and does not guarantee the accuracy of any information in Business Profiles. As a matter of policy, BBB does not endorse any product, service, or business. Businesses are under no obligation to seek BBB accreditation, and some businesses are not accredited because they have not sought BBB accreditation.

When considering complaint information, please consider the company's size and volume of transactions. Note that the nature of complaints and a company’s responses to them are often more important than the number of complaints. BBB Business Profiles generally cover a three-year reporting period.